BNET Industries

Market Cap:$1.6B
Last Fiscal Year Sales:$234.7M
  • Public
  • US
Dow Jones Description

Thoratec Corporation (we, our, us, or the Company) is the world leader in mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. We develop, manufacture and market proprietary medical devices used for circulatory support. We also develop, manufacture and market point-of-care diagnostic test systems and skin incision products. Our business is comprised of two operating divisions: Cardiovascular and International Technidyne Corporation (ITC), a wholly owned subsidiary. For advanced heart failure (HF), our Cardiovascular division develops, manufactures and markets proprietary medical devices used for mechanical circulatory support (MCS). Our primary product lines are our ventricular assist devices (VADs): the Thoratec Paracorporeal Ventricular Assist Device (PVAD), the Thoratec Implantable Ventricular Assist Device (IVAD), the HeartMate Left Ventricular Assist System (HeartMate XVE), and the HeartMate II Left Ventricular Assist System (HeartMate II). We refer to the PVAD and the IVAD collectively as the Thoratec product line and we refer to the HeartMate XVE and the HeartMate II collectively as the HeartMate product line. The PVAD, IVAD, HeartMate XVE and HeartMate II are approved by the U.S Food and Drug Administration (FDA) and Conformite Europeene (CE) Mark approved in Europe. ...

Number of Employees 1,110
Contact Information

6035 Stoneridge Dr

Pleasanton, California 94588-3270

thoratec.com

(925) 847-8600

NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510

Recent Events

  • Thoratec THOR Releases Data for HeartMate II Pivotal Trial

    11/17/09 - Product Announcement - View Story

  • Barrington Research Initiates Coverage on Thoratec THOR with an Outperform

    11/16/09 - Bond / Stock Rating - View Story

  • Market Report -- Short Stories THOR

    11/05/09 - Bond / Stock Rating - View Story

  • Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine...

    11/05/09 - Financial Announcement - View Story

  • Wells Fargo Initiates Coverage on Thoratec Corp. THOR with an Outperform; Expectations For 2009 Appear...

    9/09/09 - Bond / Stock Rating - View Story

  • Thoratec Reports 20 Percent Growth in Second Quarter Cardiovascular Division Revenues as Overall Sales Increase...

    8/06/09 - Financial Announcement - View Story

  • UPDATE 2-Thoratec drops effort to buy HeartWare

    7/31/09 - Bond / Stock Rating - View Story

  • Thoratec Isn't Heartbroken

    8/07/09 - Merger / Acquisition - View Story

News & Analysis

thoratec corp. - All News and Analysis

advertisement
     THOR $29.06 -0.26 (-0.89% )
Average Volume 743,296
Shares Outstanding 56.87M
Market Cap 1.7B
Year High 33.43
Year Low 18.56
Earnings Per Share 0.44
P/E Ratio 66.05
Dividend N/A
Yield N/A
advertisement
Click Here